Status:
COMPLETED
Co-administration of Dexmedetomidine in Carotid Endarterectomy (CEA)
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Carotid Stenosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
All neurosurgical patients at the Neurosurgery University Hospital Bern who will be operated for carotid endarterectomy (CEA) are routinely operated in deep anae¬sthesia with suppression of the electr...
Detailed Description
In the investigators clinic, as a neuroprotective measure, all neurosurgical patients operated for carotid endarterectomy (CEA) are routinely operated in deep anaesthesia with suppression of the elect...
Eligibility Criteria
Inclusion
- Inclusion criteria are:
- Age ≥18 years
- ASA physical status 1-4
- written informed consent provided.
- Exclusion Criteria:
- Age \<18 years
- higher grade atrioventricular block without pacemaker
- severe hypovolaemia or bradycardia
- uncontrolled hyper- or hypotension
- hypersensibility concerning the active substance dexmedetomidine or any other component
- serve liver disease
- known malignant hyperthermia
- cardiovascular instability or severe heart failure (\> NYHA III)
- limited peripheral autonomic activity
- pregnancy
- rejection or lack of consent of the patient or their relatives.
Exclusion
Key Trial Info
Start Date :
November 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04662177
Start Date
November 21 2018
End Date
December 4 2020
Last Update
December 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital Bern
Bern, Switzerland, 3010